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Abstract : Remarkable alteration in bio – therapeutic toxicity may occur as a result of physicochemical deterioration of 
active pharmaceutical ingredients or drugs hence the need for drug stability studies. The aim of this research was to 
investigate the stability of mirtazapine in nano-emulsion and to establish the shelf life of mirtazapine in the formulation. 
Nanoemulsion was prepared by spontaneous emulsification method (titration method). Thermodynamic stability studies 
on the nanoemulsions were performed at various temperatures. Particle sizes, polydispersity index, zeta potential were 
used to characterize the nanoemulsions. Physicochemical properties were determined on the optimized nanoemulsions 
using standard methods. Mirtazapine was incorporated into the oil phase in 1.5 % w/v to give an oil/water nanoemulsion 
formulation. The ICH protocols were observed in carrying out the stability studies for a period of three months. 
Determination of the shelf life of the nano-emulsion formulation was achieved following accelerated stability studies at 
4 ± 0.7 °C, 25 ± 0.5 °C, 40 ± 0.5 °C, 50 ± 0.4 °C and 65 % ± 5 relative humidity (RH). Result showed that the droplet size, 
conductivity, refractive index were slightly increased while the pH and viscosity slightly decreased during the 3 months 
period. The observed slight changes in the parameters were not statistically significant (p • 0.05). The shelf life was 
found to be 2.88 years at room temperature. The degradation (%) of the optimized mirtazapine nanoemulsion was 
determined. This research work confirmed that the physicochemical stability of mirtazapine was enhanced in the 
nanoemulsion. 
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Introduction 
The integrity and quality of drug preparation changes under the influence of certain environmental factors 
such as light, humidity and temperature. World Health Organization has been addressing the salient issues as 
it relates to drug stability and storage with particular attention to the developing countries most of which are 
located in the tropical climate zones where drug stability poses more serious problems which may lead to 
changes in the shelf-life of the pharmaceutical product [1]. Nanoemulsions are isotropic, thermodynamically 
stable, transparent system of oil, water and surfactants with a droplet size range of 20 – 200 nm [2]. 
Nanoemulsions may become unstable due to the effect of environmental factors on the globular size leading 
to coalescence, flocculation and Ostwalds ripening [3-6]. This calls for standard protocol on stability studies 
on the formulated products. An increase in the mean globular size with time coupled with a decrease in 
globular number could be attributed to coalescence in the nanoemulsion formulation [7], as such, a careful 
stability studies using microscopic examination or electronic particle counting device such as the Photon 
Correlation Microscope with Zetta- sizer [8] and the Transmission Electron Microscope [9] were conducted. 
Oswald ripening is an irreversible transfer of small globlets into a larger one so as to form entirely new ones 
with larger size. In flocculation, several smaller droplets come together to form floccules, this may result in 
creaming. The above three factors may lead to total breakdown of an emulsion formulation giving rise to an 
observed phase inversion of the dispersed system.  
 Accelerated stability studies are carried out to check the effect of the above factors on the overall 
integrity and quality of the mirtazapine loaded nanoemulsion formulation. Change in viscosity can equally 
be used as a study tool in determining the stability of nanoemulsions, any variation in globular size or 
number, or in the orientation or migration of emulsifier over a period of time may be detected by a change in 
apparent viscosity. In order to compare the relative stabilities of range of similar products, it is often 
necessary to speed up the process of creaming and coalescence. This can be achieved by means of 
exaggerating temperature fluctuations to which any product is subjected under normal storage condition and 
this is the basis of accelerated stability studies. Change in the droplet size as well as droplet count is 
measured by the use of Transmission Electron Microscope or the Scanning Electron Microscope, while the 
use of Photon Correlation Microscope with Zetta-sizer is essential for Zeta-potential determination. 
Mirtazapine, [±]-2-methyl-1,2,3,4,10,14b-hexahydropyrazino-[2,1-9]pyrido[2,3-e]benzazopine whose 
chemical structure is presented in Figure 1, is a tetracyclic antidepressant drug that exist as enantiomers and 
both enantiomers contributes to the antidepressant activity. Clinically, mirtazapine is used for the treatment 
of moderate to severe depression and anxiety.  
 
 
 
Figure 1 Chemical structure of mirtazapine. 
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Mirtazapine is available only as tablets in doses of 15, 30 and 45 mg respectively [10]. The drug is 
practically insoluble in water and its logarithm partition coefficient (Otanol-water) is 2.9, indicating high 
hydrophobicity hence the nanoemulsion is oil in water type. In this work, the stability of mirtazapine loaded 
nano-emulsion was investigated and the shelf-life of such nano-emulsion formulation was established. 
Materials and methods 
Materials   
Mirtazapine was purchased from Mylan Pharmaceuticals, (USA), Propylene glycol, Sodium lauryl sulphate 
(Sigma- Aldrich, USA). Sunflower oil of analytical grade was used without further purification. 
 
Preparation of Mirtazapine loaded Nanoemulsion 
The water titration method was employed [11] in this study. Mirtazapine (1.5 % w/v) was dissolved into 
co-surfactant or Smix in a beaker and warmed at 37 °C in a water-bath and mixed. The drug was dissolved; 
this was followed by slow titration with aqueous phase to get a clear final preparation of 100 % (v/v). 
Nanoemulsion was prepared by subjecting the sample to homogenization using Virtis 6-105 Homogenizer at 
50 Hz for 10 minutes. 
 
Characterization of Nanoemulsions (Droplet Size and Morphology)  
Size and size distribution 
The Photon Correlation Microscope with Zeta-Sizer (Malvern Nano ZS.ZS 290.UK) and Transmission 
Electron Microscope (VEGAimuGmbH,Germany), were used to characterize the nanoemulsions. Droplet 
size and morphology of the nano-emulsions were studied using TEM ( operating at 200 KV) at increasing 
magnification and diffraction modes. Sample preparation involved placing a drop of 1 in 100 ml dilution of 
nanoemulsion on a copper grid, allowed to dry and further sealed with a monolayer of gold. After drying, the 
sample was photographed by transmission electron microscopy. 
 
Viscosity Measurement 
The viscosity of nano-emulsion was measured using the small sample adaptor of a Brookfield rheometer 
(Model DV-III, Brookfield Eng. Labs, Inc., Stoughton, MA, USA) at 25 °C. An average of three data points 
was obtained to determine the viscosity at a shear rate of 7.34s [12]. 
 
Refractive Index and pH Measurement  
 The refractive index (RI) of the nano-emulsion was determined using an Abbe-refractometer 
[13] whereas, the pH of the samples was done using a pre-calibrated pH meter. A 5 ml of the 
sample was transferred into a beaker and pH meter probe was immersed into the container and 
the pH reading recorded. The pH of the freshly prepared formulation was measured and 
compared with the changes in pH of the formulation after specified intervals at the different 
studied temperatures. 
 
  
 
Ivy Union Publishing | http: //www.ivyunion.org February 21, 2018 | Volume 6 | Issue 1  
Kenneth EM et al. American Journal of Nanoscience & Nanotechnology Research. 2018, 6:8-17 
   
Page 4 of 10 
Conductivity Measurement [14] 
Conductivity of nano-emulsion sample was measured using a conductometer (Cyberscan, Eutech 
Instrument, Singapore). A 2 ml sample was transferred into a beaker and the conductivity measured and 
recorded. The conductivity of the freshly prepared formulation was measured and the result was compared 
with the change in conductivity of the formulation after a period of 90 days at 30 days interval at different 
temperatures under study. 
 
Statistical Analysis 
Statistical analysis was performed using one-way Anova test to determine the difference of all 
the parameters studied initially and after 90 days of observation at all storage conditions. A 
significant difference was considered at a p-value of less than 0.05. 
 
Stability Studies in line with ICH Protocols. 
Accelerated stability studies were performed on optimized mirtazapine nano-emulsions in line with 
International Conference on Harmonization (ICH) protocols [15]. Replicates of the prepared samples were 
kept at refrigerator temperature (4 ± 0.7 °C), room temperature (25 ± 0.5 °C/60 ± 5 % RH.) and 40 ± 0.5 °C 
/75 ± 5 % RH. Samples were withdrawn at 0, 30, 60 and 90 days. The samples were evaluated for droplet 
size, viscosity, pH, conductivity and refractive index. Three batches of the optimized mirtazapine 
nano-emulsion were equally taken in a glass vial and kept at accelerated temperatures of 30, 40, 50 and 60 
°C at ambient humidity, samples were taken and analyzed for mirtazapine content using 
UV-Spectrophotometer at 290 nm. 
 
Determination of Shelf-Life [16] 
Withdrawn samples were extracted by dissolving in methanol. Drug content in the solvent extracted was 
analysed spectrophotometrically against standard solvent solution of mirtazapine. The concentration of 
mirtazapine in the nano-emulsion formulation at different elevated temperatures were established and 
recorded. Samples of pure sunflower oil and surfactant-co-surfactant mixture without mirtazapine were also 
ran separately to check the interference of excipients used. The amount of drug decomposed and the amount 
remaining at each time interval was calculated. The degradation order was determined by a graphical 
method, while degradation rate constant (K) was determined at each temperature. An Arrhenius plot was 
constructed between log K and 1/T to determine the Shelf-Life of the optimized nano-emulsion formulation. 
The degradation rate constant at 25 °C (K25) was determined by extrapolating the value at 25
 °C from the 
Arrhenius plot. The Shelf-Life (T0.9) of formulation was determined using (equation 1): 
 
Shelf Life = 0.1052/K...........................equation 1     
                                                                                 
Where: K is the degradation rate constant. (Dimensionless) 
Results   
The results obtained from the experiments and measurements are presented in Tables 1-4 and 
Figures 2-5. 
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Table 1 Droplet-size, viscosity, refractive-index and conductivity of optimized nano-emulsion, during the period 
of 90 days of storage 
 
Time 
(days) 
Temp.( °C) Mean droplet 
size(nm)±SD (n=3) 
Mean viscosity 
(mp)±SD (n=3) 
RI±SD (n=3) pH±SD (n=3) Conductivity (µs) 
±SD, (n=3) 
0 
30 
60 
90 
4 ± 0.7 
4 ± 0.7 
4 ± 0.7 
4 ± 0.7 
128.2 ± 0.7 
128.9 ± 0.3 
128.5 ± 0.7 
128.4 ± 0.8 
33.2 ± 1.1 
32.8 ± 1.2 
32.8 ± 1.1 
32.9 ± 1.0 
1.416 ± 0.02 
1.512 ± 0.01 
1.514 ± 0.02 
1.520 ± 0.01 
8.4 ± 0.01 
8.4 ± 0.01 
8.4 ± 0.03 
8.4 ± 0.02 
250 ± 3.2 
251 ± 2.2 
250 ± 3.2 
250 ± 2.2 
0 
30 
60 
90 
25 ± 0.5 
25 ± 0.5 
25 ± 0.5 
25 ± 0.5 
128.1 ± 0.3 
128.4 ± 0.2 
129.2 ± 0.1 
129.8 ± 0.3 
32.4 ± 1.0 
32.4 ± 1.2 
32.3 ± 1.0 
32.2 ± 1.2 
1.500 ± 0.02 
1.510 ± 0.01 
1.512 ± 0.02 
1.513 ± 0.03 
8.3 ± 0.02 
8.2 ± 0.01 
8.1 ± 0.03 
8.1 ± 0.01 
251 ± 3.4 
251 ± 1.0 
252 ± 2.0 
252 ± 1.0 
0 
30 
60 
90 
40 ± 0.5 
40 ± 0.5 
40 ± 0.5 
40 ± 0.5 
128.6 ± 0.2 
129.4 ± 0.4 
129.8 ± 0.8 
129.9 ± 0.7 
32.1 ± 2.0 
31.8 ± 1.2 
31.6 ± 2.0 
31.0 ± 1.0 
1.512 ± 0.08 
1.513 ± 0.09 
1.514 ± 0.06 
1.514 ± 0.08 
8.1 ± 0.02 
8.0 ± 0.08 
8.0 ± 0.05 
8.0 ± 0.02 
252 ± 4.0 
253 ± 2.0 
253 ± 4.0 
254 ± 2.0 
 
Table 2 Degradation of optimized nano-emulsions. 
Time (days) Temp.(oC) Drug content (mg) Drug conc.degraded (mg) % drug remaining Log (%) drug remaining. 
0 
30 
60 
90 
4 ± 0.7 
4 ± 0.7 
4 ± 0.7 
4 ± 0.7 
15.000 
14.960 
14.900 
14.835 
0 
0.040 
0.100 
0.165 
100 
99.733 
99.333 
98.900 
2 
1.9988 
1.9970 
1.9950 
0 
30 
60 
90 
25 ± 0.5 
25 ± 0.5 
25 ± 0.5 
25 ± 0.5 
15.000 
14.915 
14.830 
14.755 
0 
0.085 
0.170 
0.245 
100 
99.433 
98.867 
98.367 
2 
1.9975 
1.9951 
1.9926 
0 
30 
60 
90 
40 ± 0.5 
40 ± 0.5 
40 ± 0.5  
40 ± 0.5 
15.000 
14.900 
14.810 
14.715 
0 
0.100 
0.190 
0.285 
100 
98.333 
98.733 
98.200 
2 
1.9970 
1.9945 
1.9821 
0 
30 
60 
90 
50 ± 0.4 
50 ± 0.4 
50 ± 0.4 
50 ± 0.4 
15.000 
14.860 
14.750 
14.675 
0 
0.140 
0.250 
0.325 
100 
99.066 
98.333 
97.833 
2 
1.9959 
1.9926 
1.9912 
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The correlation coefficient when compared for Figure 1 and Figure 2 shows that the coefficients for 
first-order is more reliable as compared to the zero-order, hence it was confirmed that the degradation of 
mirtazapine follows a first-order kinetics. As such, the log % of drug remaining was plotted against time 
(Fig.1) and K was calculated from the slope of the curve at each temperature (equation 2). The results are 
presented in Table 3. 
 
Slope = - 2.303K....................equation 2    
                  
Where: K is the degradation rate constant. 
 
 
Table 3 Temperature, K (day-1) and Absolute temperature. 
    Temp.( °C)       Slope K (day-1) log K Absolute Temp.(T) 1/T x 10-3  
4 -0.000056 0.000129 -3.88849 277 3.610108 
25 -0.000008 0.000184 -3.73462 298 3.355705 
40 -0.000087 0.000201 -3.69653 313 3.194888 
50 -0.000108 0.000248 -3.60562 323 3.095975 
 
 
 
 
 
 
 
 
 
Figure 2 Size distribution by intensity 
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Figure 3 First-order degradation kinetics of mirtazapine from optimised nano-     emulsions, at different 
temperatures. 
 
 
 
 
Figure 4 Zero-order degradation kinetics of mirtazapine from the optimized nano-emulsions at different 
temperatures 
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Figure 5 A graph of log K against 1/T x 10-3 
 The shelf-life of mirtazapine-loaded nanoemulsion was observed from calculation using 
equation 1 to be 2.88 years. 
Discussion 
Accelerated stability studies are particularly useful for assessing how the quality of a drug varies over time 
under the influence of a variety of factors such as humidity, temperature and light. A drug proto-type must be 
fully assessed with regards to its physical, chemical and microbiological characteristics at the start of study 
and throughout the intended shelf life period. Optimised nano-emulsion formulation subjected to 
accelerated stability studies were evaluated on the basis of droplet size, viscosity, pH, conductivity and 
refractive index for the period of 90 days. The study showed that there was no significant change in all the 
parameters after 90 days. The refractive index, conductivity and droplet size were slightly increased while 
the pH and viscosity decreased. The stability of the mirtazapine nano-emulsion was also checked at 
refrigerator (4 °C) and room temperature (25 °C). The study showed that there was no significant change in 
all the parameters during the 90 days period of storage. 
 Statistically, the changes in these parameters were not significant (p • 0.05). These results justified 
the fact that the optimized formulations were stable as there were no significant changes in the physical 
parameters (droplet size, viscosity, pH, conductivity and refractive index). The degradation of mirtazapine 
was very slow at each temperature which indicated the chemical stability of mirtazapine in the 
nano-emulsion formulation below room temperature. The optimized nano-emulsion was found to be 
physicochemically stable. 
 The order of degradation of active pharmaceutical ingredient (mirtazapine) was determined at 
each temperature by a graphical method. The degraded and remaining concentrations of mirtazapine at 
different temperature are shown in Table 3 and the degradation partern was found to be first-order (Figure 
3.) 
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Conclusion 
The simple water titration method was effective in achieving reproducible mirtazapine nano-emulsion with 
the desired physicho-chemical and safety characteristics. The shelf life from the Arhenius plot was found to 
be 2.88 years at room temperature and the degradation (%) of the optimized mirtazapine nano-emulsion was 
determined (Table 2), thus establishing that the physicochemical stability of mirtazapine was enhanced in 
the nanoemulsion. 
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